PMID- 37023915
OWN - NLM
STAT- MEDLINE
DCOM- 20230925
LR  - 20230925
IS  - 1615-5947 (Electronic)
IS  - 0890-5096 (Linking)
VI  - 96
DP  - 2023 Oct
TI  - Efficacy and Safety of Percutaneous Venoarterial Extracorporeal Membrane 
      Oxygenation Decannulation Using Endovascular Balloon Dilation and Perclose 
      ProGlide Closure Device: Results from the Multicenter SKYLINE Study.
PG  - 357-364
LID - S0890-5096(23)00193-0 [pii]
LID - 10.1016/j.avsg.2023.03.025 [doi]
AB  - BACKGROUND: The venoarterial extracorporeal membrane oxygenation (VA-ECMO) 
      cannula can be surgically removed, but postoperative complications and surgical 
      staffing issues can be problematic. We previously reported a method of 
      percutaneously removing the arterial cannula of VA-ECMO by combining 
      intravascular balloon dilation and the Perclose ProGlide (PP) closure device. In 
      this study, we investigated the efficacy and safety of this percutaneous 
      decannulation of the VA-ECMO. METHODS: This multicenter, retrospective study 
      involved consecutive patients who underwent percutaneous VA-ECMO decannulation at 
      2 cardiovascular centers from September 2019 to December 2021. We analyzed 37 
      patients in whom the VA-ECMO cannula was removed by the percutaneous procedure 
      with balloon dilation and the PP. The primary end point was procedural success of 
      hemostasis. The secondary end points were the procedural time, procedure-related 
      complications, and rate of surgical conversion. RESULTS: The patients' mean age 
      was 65.4 years. The approach site of the endovascular therapy (EVT) procedures 
      were the transradial approach (56.8%), transfemoral approach (27.8%), and 
      transbrachial approach (18.9%). The mean balloon diameter was 7.3 +/- 0.68 mm, and 
      the mean balloon inflation time was 14.8 +/- 7.3 min. The mean procedure time was 
      58.5 +/- 27.0 min. The procedure success rate was 94.6%, procedure-related 
      complication rate was 10.8%, procedure-related death and postprocedural infection 
      rate was 0.0%, surgical conversion rate was 0.0%, and EVT access site 
      complication rate was 2.7%. CONCLUSIONS: We concluded that percutaneous VA-ECMO 
      decannulation using a combination of intravascular balloon dilation in EVT and 
      the PP appears to be a safe, minimally invasive, and effective procedure.
CI  - Copyright (c) 2023 Elsevier Inc. All rights reserved.
FAU - Hayakawa, Naoki
AU  - Hayakawa N
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan. 
      Electronic address: haya.naoki1981@gmail.com.
FAU - Tobita, Kazuki
AU  - Tobita K
AD  - Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.
FAU - Kodera, Satoshi
AU  - Kodera S
AD  - Department of Cardiovascular Medicine, University of Tokyo Hospital, Tokyo, 
      Japan.
FAU - Koyama, Eiji
AU  - Koyama E
AD  - Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.
FAU - Miyashitata, Hirokazu
AU  - Miyashitata H
AD  - Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.
FAU - Sahashi, Syuichi
AU  - Sahashi S
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Ichihara, Shinya
AU  - Ichihara S
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Arakawa, Masataka
AU  - Arakawa M
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Hirano, Satoshi
AU  - Hirano S
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Inoguchi, Yasunori
AU  - Inoguchi Y
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Shakya, Sandeep
AU  - Shakya S
AD  - Department of Cardiovascular Medicine, Kawakita General Hospital, Tokyo, Japan.
FAU - Miyaji, Kotaro
AU  - Miyaji K
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Kushida, Syunichi
AU  - Kushida S
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Kanda, Junji
AU  - Kanda J
AD  - Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
FAU - Saito, Shigeru
AU  - Saito S
AD  - Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
DEP - 20230405
PL  - Netherlands
TA  - Ann Vasc Surg
JT  - Annals of vascular surgery
JID - 8703941
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Extracorporeal Membrane Oxygenation/adverse effects
MH  - Retrospective Studies
MH  - Dilatation
MH  - Femoral Artery/surgery
MH  - Treatment Outcome
EDAT- 2023/04/07 06:00
MHDA- 2023/09/25 06:42
CRDT- 2023/04/06 19:25
PHST- 2023/01/28 00:00 [received]
PHST- 2023/03/19 00:00 [revised]
PHST- 2023/03/20 00:00 [accepted]
PHST- 2023/09/25 06:42 [medline]
PHST- 2023/04/07 06:00 [pubmed]
PHST- 2023/04/06 19:25 [entrez]
AID - S0890-5096(23)00193-0 [pii]
AID - 10.1016/j.avsg.2023.03.025 [doi]
PST - ppublish
SO  - Ann Vasc Surg. 2023 Oct;96:357-364. doi: 10.1016/j.avsg.2023.03.025. Epub 2023 
      Apr 5.